Ultragenyx
Price & Volume
Stats
See more52W Range | $18.29-$39.88 |
Market Cap | $3.3B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $670M |
Revenue Growth (YoY) | -2.2% |
Gross Profit (12 Mos) | -$188M |
Diluted EPS | -$6.10 |
News
See moreYahoo Finance • 25 days ago
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE)
Yahoo Finance • last month
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year
Yahoo Finance • 2 months ago
Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial
About
CEO | Dr. Emil D. Kakkis M.D., Ph.D. |
CFO | Mr. Howard Horn |
Address | 60 Leveroni Court, Novato, CA, United States, 94949 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,371 |